Karen L. Smith serves as Executive at Jazz Pharmaceuticals plc, where they oversee executive responsibilities. Since joining the company, Karen L. Smith has executed 52 insider transactions totaling $3.1M, demonstrating a bearish approach to their equity position. Their most recent transaction on May 11, 2015 involved receiving (via award) 6,830 shares valued at $0.
Karen L. Smith currently holds 35,000 shares of Jazz Pharmaceuticals plc (JAZZ), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Karen L. Smith has been a net seller of JAZZ stock. They have purchased $250.0K and sold $2.9M worth of shares.
Karen L. Smith's most recent insider trade was on May 11, 2015, when they sold 6,830 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |